Primary resected meningiomas: Relapses and proliferation markers

In Vivo

Volumn 18, Issue 4, 2004, Pages 411-416

  Kalala, Jean Pierre ^a   Caemaert, Jacques ^a   de Ridder, Leo ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Meningiomas; Proliferation markers; Recurrence; Regrowth; Relapse; Risk factors

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODENSITOMETRY; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM;

EID: 4444237856     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cushing H and Eisenhardt L: The Meningiomas: Their Classification, Regional Behaviour, Life History and Surgical End Results. Springfield, III, Charles C Thomas. 1938.
2. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG and Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18-24, 1985.
3. Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr and Million RR: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15: 299-304, 1988.
4. Abramovich CM and Prayson Richard A: Histopathologic features and MIB labelling indices in recurrent and non recurrent meningiomas. Arch Pathol Lab Med 123: 793-800, 1999.
5. Perry AB, Stafford S, Scheithauer BW, Suman VJ and Lohse CM: Meningioma grading: analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997.
6. Jellinger K and Slovik F: Histologic subtypes and prognostic problems in meningiomas. J Neurol 208: 279-298, 1975.
7. May PL, Broome JC, Lawry J, Buxton RA and Battersby RDE: The prediction of recurrence in meningiomas. J Neurosurg 71: 347-351, 1989.
8. Philippon J and Cornu P: The recurrence of meningiomas. In: Meningiomas (Al-Mefty O ed). New York, Raven Press, 1991, pp 87-105.
9. Kepes JJ: Review of the WHO's new proposed classification of brain tumours. Proceedings of the XIth International Congress of Neuropathology, Kyoto, Japan: 87-97, 1990.
10. Moller M and Braendstrup O: No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34(3): 241-246, 1997.
11. Kostantinidou A, Pavlopoulos P, Patsouris E, Kaklamanis L and Davaris P: Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186(3): 325-330, 1998.
12. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39, 1957.
13. Gerdes J, Schwab U, Lemke H and Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
14. Bravo R, Frank R, Blundell PA and Mac Donald-Bravo H: Cyclin/PCNA is the auxillary protein of DNA polymerase-δ. Nature 326: 515-517, 1987.
15. Hues P and Cavenee WK: Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours. Lyon, 2000.
16. Stafford SL, Perry AB, Suman V, Meyer FB, Scheithauer BW, Lohse CM and Shaw EG: Primarly resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clinic Procedure 73: 936-942, 1998.
17. Jääskeläinen J, Hatia M and Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25: 233-242, 1986.
18. Jay JR, Mac Laughlin DT, Riley KR and Matura RL: Modulation of meningioma cell growth by sex hormones in vitro. J Neurosurg 62: 757-762, 1985.
19. Goldsmith BJ, Wara WM, Wilson CB and Larson DA: Postoperative irradiation for sub totally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neursurg 80(2): 195-201, 1994.
20. Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gomez PA and Cabrera A: Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochirgica (Wien) 141: 921-932, 1999.
21. Borovitch B and Doron Y: Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64(1): 58-63, 1986.
22. Kamitani H, Masuzawa H, Kanazawa I and Kubo T: Recurrence of convexity meningiomas: tumor cells in the arachnoid membrane. Surg Neurol 56(4): 228-235, 2001.
23. Black PM: Meningiomas. Neurosurg 32: 643-657, 1993.
24. Rubinstein AB, Shalèt MN, Cohen ML, Zandbank U and Reichenthal E: Radiation induced cerebral meningioma: a recognizable entity. J Neurosurg 61: 966-971, 1984.
25. Von Deimling A, Larson J, Wellesreutherr R, Stangl AP, Van Velthoven V, Warnick R, Tew J, Balko G and Menon A: Clonal origin of recurrent meningiomas. Brain Pathol 9(4): 645-650, 1999.
26. Roggendorff W, Schuster T and Pfeiffert J: Proliferative potential of meningiomas determined with monoclonal antibody Ki67. Acta Neuropathologica (Bul) 73: 361-364, 1987.
27. Jellinger K: Biologic behaviour of meningiomas. In: Primary Brain Tumours. A Review of Histologic Classification. (Fields WS, ed.)Springer Verlag Chapter XII, 1989, pp 231-240.
28. Cerda N, Lopez-Genéz G, Perez-Bocete M, Barcia-Solario J and Llombart-Basel A: Histopathological and cytogenetic findings in benign, atypical and malignant human meningioma: a study of 60 tumors. J Neurooncol 47(2): 99-108, 2000.
29. Mallez M L and Braendstrup O: No prediction of recurrence of meningiomas by PCNA and Ki67 immunochemistry. J Neuroncol 34(3): 241-246, 1997.
30. Sudha K, Karak AR, Sharma MC, Mathu M and Sarkar C: Assesment of proliferative potential of meningiomas using PCNA LI and AgNOR counts. Indian J Pathol Microbiol 41(3): 323-330, 1998.
31. Konstantinidou AF, Paralopoulos PM, Patronius E, Kaklamanisius L and Davaris C: Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186(3): 325-330, 1989.